Semaglutide and Tirzepatide Show Real-World Promise in Cutting Heart Failure Hospitalizations and Deaths in Diabetic HFpEF Patients
New Real-World Evidence Links GLP-1 / GIP Therapy With Lower Risk of HF Hospitalization and Mortality in HFpEF Patients With Diabetes Boston / Munich, August …